• OPEN AN ACCOUNT
Indian Indices
Nifty
24,946.50 227.90
(0.92%)
Sensex
81,518.71 -277.44
( -0.34%)
Bank Nifty
55,944.90 417.55
( 0.75%)
Nifty IT
39,073.05 603.80
( 1.57%)
Global Indices
Nasdaq
42,540.48 321.68
(0.76%)
Dow Jones
6,054.14 56.17
(0.94%)
Hang Seng
38,275.58 441.33
(1.17%)
Nikkei 225
8,875.22 24.59
(0.28%)
Forex
USD-INR
85.72 0.17
(0.19%)
EUR-INR
98.97 0.08
(0.08%)
GBP-INR
116.32 0.08
(0.07%)
JPY-INR
0.59 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Dr Lal Pathlabs Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
539524
INE600L01024
254.778098
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LALPATHLAB
49.53
24711.68
EPS(TTM)
Face Value()
Div & Yield %
59.55
10
0.81
 

stellant securities (india) ltd
NTPC to raise Rs 4,000 cr via 10-Year NCDs at 6.89%
Jun 14,2025
The company plans to issue unsecured non-convertible debentures (NCDs) amounting to Rs 4,000 crore through private placement at a coupon of 6.89% p.a. The debentures will have a tenor of 10 years and 1 day, maturing on 18 June 2035. They are proposed to be listed on National Stock Exchange (NSE).

Proceeds will be utilized for, inter alia, funding of capital expenditure, refinancing of existing loans and other general corporate purposes.

Meanwhile, the company’s unit 3 (660 MW) of North Karanpura Super Thermal Power Project (3x660 MW) declared commercial operation date (COD) with effect from 15 June 2025.

NTPC is India's largest energy conglomerate. It has presence in the entire value chain of the power generation business. As of 31 March 2025, the Government of India held 51.10% stake in the company.

The company had reported 23.4% increase in consolidated net profit to Rs 7,611.22 crore on a 4.6% rise in net sales to Rs 49,833.70 crore in Q4 FY25 compared with Q4 FY24.

The counter shed 0.43% to end at Rs 332 on Friday, 13 June 2025.